Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Rosuvastatin Prevent Contrast Induced Acute Kidney Injury in Patients With Diabetes (TRACK-D)

This study has been completed.
Information provided by (Responsible Party):
Han Yaling, MD, Shenyang Northern Hospital Identifier:
First received: November 5, 2008
Last updated: April 9, 2013
Last verified: April 2013